课题基金 / 基金详情

Improving tuberculosis diagnosis in vulnerable populations: impact and cost-effectiveness of a novel, rapid molecular assay

Improving tuberculosis diagnosis in vulnerable populations: impact and cost-effectiveness of a novel, rapid molecular assay
改善弱势群体的结核病诊断：新型快速分子检测的影响和成本效益
批准号：
224177
负责人：
Pai Madhukar
金额：
$25.91万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=224177&lang=en
关键词：
Aboriginals Cost-Effectiveness Diagnosis Test Accuracy Tuberculosis Vulnerable Populations

项目摘要

项目成果

Pai Madhukar的其他基金

相似基金

相关文献

中文摘要
翻译
结核病仍然是严重的全球公共卫生威胁，每年有940多万病例。结核病是加拿大移民和土著居民中一个重要的公共卫生问题。目前，努纳武特地区正面临该国最大的结核病疫情
英文摘要
Tuberculosis (TB) remains a severe global public health threat, with over 9.4 million cases each year. TB is an important public health problem in Canada among immigrants and Aboriginal populations. Currently, Nunavut is facing the largest TB outbreak in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Empowering informal healthcare providers to detect tuberculosis using tongue swabs: a field-based, open-label, cluster randomized trial in India
Artificial intelligence-based analysis of cough for COVID-19 screening in Montreal
Canada Reseach Chair - Tier 1
  • 批准号：
    454237
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2021
  • 负责人：
    Pai Madhukar
  • 依托单位：
    McGill University
Validation of rapid, molecular testing for COVID-19 and integration with TB diagnostics
海外基金